Responses

Original research
Association between self-monitoring of blood glucose and hepatitis B virus infection among people with diabetes mellitus: a cross-sectional study in Gansu Province, China
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Responses to critical remarks by Sarosh A. Khan
    • Bingfeng Han, Doctorial student Department of Epidemiology and Biostatistics, Peking University School of Public Health
    • Other Contributors:
      • Fuqiang Cui, Professor

    As early as 2011, Advisory Committee on Immunization Practices (ACIP) in the US recognized the high risk of hepatitis B infection in diabetic patients and recommended that all previously unvaccinated adults aged 19 through 59 years with diabetes mellitus (type 1 and type 2) be vaccinated against hepatitis B as soon as possible after a diagnosis of diabetes is made[1]. Based on more evidence, the hepatitis B vaccine position paper revised by the WHO in 2017 highlighted that the population with diabetes is at high risk of HBV infection[2]. In 2019, a guideline published by Chinese Medicine Association highlighted for the first time that the diabetic population is at high risk of HBV infection and recommended hepatitis B vaccination in China[3]. Many studies identified the high risk of hepatitis B infection in diabetic patients[4-6], however, some surveys showed that no association of HBsAg with the presence of diabetes[7,8].
    A cross-sectional study can describe the epidemiological characteristic of hepatitis B virus (HBV) infection among diabetes, however it cannot provide evidence of causality. In this study[9], we focused on the differences of HBV infection among diabetic patients compared with health people, and then analyzed the potential factors to imply possible infection pathways. When designing this study, we paid more attention to the situation of individuals, including demographic characteristics and frequency of monitoring blood glucose. We took individuals...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Diabetes and SMBG per se do not increase the risk of Hepatitis B.

    Thanks for the paper on an important topic of immense significance. However, the paper does not tell us the following:
    1. How many patients with diabetes were sharing the glucometers?
    2. How many patients with diabetes were sharing insulin needles?
    3. How many in the same family had diabetes?
    4. How many in the family of these patients with diabetes had a family member carrying HBsAg?
    China having the highest number of patients with HBsAg carrier state means one has to be extra-cautious while using glucometers and changing the lancets every single time. Also making sure to use disposable syringes or at least not sharing the insulin syringes. Moreover all members of a diabetic patient should be screened for HBsAg. And all diabetic patients should get HB vaccination.
    The conclusion that "Routine blood glucose monitoring at home was associated with HBV infection, which meant people with diabetes may be at high risk of HBV infection" is misleading. It is the sharing of contaminated lancets and needles which are responsible.
    Lastly question B1 in the Appendix A is hilarious.

    Conflict of Interest:
    None declared.